40岁以下喉癌患者特征与生存分析
该回顾性研究纳入2005至2014年三级转诊中心治疗的160例喉鳞状细胞癌患者,其中13例诊断时年龄小于40岁。年轻组吸烟比例较低但初诊分期更晚,5年生存率低于年长组;按早期和晚期分层后两组总生存与5年生存率无显著差异。
要点
- 年轻组吸烟比例较低,提示病因可能不同于年长组。
- 年轻组初诊分期更晚,III或IV期占62%。
- 按分期分层后两组生存无显著差异。
核心结论
- 年轻喉癌患者的经典危险因素患病率较低,提示病因可能不同于年长组;年轻组初诊分期更晚且5年生存率更差,但按早期和晚期分层后两组总生存或5年生存率无显著差异。
研究设计与样本
- 回顾性病历审查,纳入2005至2014年某三级转诊中心治疗的所有喉鳞状细胞癌患者,研究组共160例,其中诊断时年龄小于40岁者13例。
- 年轻组平均年龄35±3.9岁,年长组平均年龄64.4±11岁。
- 证据等级为4。
主要发现
- 年轻组吸烟者占38%(平均2.2包/天),年长组占71%(平均3包/天)。
- 年轻组初诊分期更晚:8例(62%)为III或IV期,年长组49例(33%)为III或IV期(P = .042)。
- 年轻组平均总生存6.7±1年,年长组7.7±0.2年(P = .2)。
- 年轻组5年生存率69%,年长组90%(P = .04)。
- 按早期和晚期疾病分层后,两组总生存或5年生存率均无显著差异。
临床怎么用
- 对40岁以下喉癌患者应关注初诊分期可能偏晚,评估时不宜仅凭经典危险因素阴性而降低警惕。
- 生存比较需按早期与晚期分层解读,避免将总体5年生存差异直接归因于年龄。
局限性
- 为单中心回顾性病历审查,证据等级4。
- 年轻组仅13例,样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To assess the differences between patients with laryngeal squamous cell carcinoma under 40 years old and those 40 years old or older. A secondary objective was to compare survival outcome between these cohorts. STUDY DESIGN: Retrospective chart review. METHODS: We reviewed the medical charts of all patients treated in our tertiary referral center for laryngeal squamous cell carcinoma from 2005 to 2014. Patients aged < 40 years at diagnosis were compared to older patients. RESULTS: The study group comprised 160 patients. Of them, 13 were aged < 40 years at diagnosis. Mean age was 35 ± 3.9 years and 64.4 ± 11 years for the two groups. Among the younger patients, 38% were smokers (mean pack/day, 2.2) versus 71% in the older group (mean pack/day, 3). The younger group typically had a more advanced stage than the older group at presentation; eight young patients (62%) had stage III or IV versus 49 (33%) in the older group (P = .042). Mean overall survival was 6.7 ± 1 years for those under 40 years old and 7.7 ± 0.2 years for the older patients (P = .2). The 5-year survival rate was 69% for young patients and 90% for the older group (P = .04). However, there was no significant between-group difference in overall survival or 5-year survival rate when stratified for early- and late-stage disease. CONCLUSIONS: There is a lower prevalence of classic risk factors in younger patient with laryngeal carcinoma in this study, suggesting a different etiology compared to our older cohort. The under-40 cohort presented with more advanced disease and had a worse 5-year survival; however, when stratified for early- versus late-stage disease, there was no significant difference in overall or 5-year survival between the groups. This may suggest that, despite a different etiology, laryngeal cancer behaves similarly in older and younger patients. LEVEL OF EVIDENCE: 4. Laryngoscope, 128:1602-1605, 2018.
引用
- Nachalon Y, Alkan U, Shvero J, et al. Assessment of laryngeal cancer in patients younger than 40 years. Laryngoscope. 2017. PMID: 29076536. doi:10.1002/lary.26951
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。